Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Antoine Khalil"'
Autor:
Claire Danel, Aurélie Sannier, Jean-Michel Rodier, Anne Couvelard, S. Brosseau, Hussein Nassereddine, Aurélie Cazes, Antoine Khalil, Simon Msika, Nathalie Théou-Anton
Publikováno v:
Pathology & Oncology Research. 26:2795-2800
To retrospectively characterize the molecular features of Non-Small Cell Lung Carcinomas (NSCLC) with peritoneal carcinomatosis (PC), clinicopathological data of 12 patients diagnosed with NSCLC and PC between 2007 and 2016 were collected. Immunohist
Autor:
B. Abbar, Céline Namour, Sandra Assoun, Benjamin Besse, C. Tesmoingt, Paul Gougis, Gérard Zalcman, Antoine Khalil, Nathalie Théou-Anton, Aurélie Cazes, V. De Castelbajac, Valérie Gounant, J. Pluvy, S. Brosseau
Publikováno v:
Lung Cancer
Lung Cancer, Elsevier, 2021, 152, pp.109-118. ⟨10.1016/j.lungcan.2020.12.026⟩
Lung Cancer, Elsevier, 2021, 152, pp.109-118. ⟨10.1016/j.lungcan.2020.12.026⟩
Background The advent of immune checkpoint inhibitors (ICI) has been a breakthrough in the care of patients with non-small-cell lung cancers (NSCLC). However, physicians are now facing a previously unidentified clinical situation called hyperprogress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783fe60cadfbba5e22641c06aa9b612a
https://hal.archives-ouvertes.fr/hal-03493902
https://hal.archives-ouvertes.fr/hal-03493902
Autor:
Nathalie Lassau, N. Abassebay, I. Hammouamri, A. Loubet, M. Deloche, J.-A. Broyelle, D. Blanc, J. Brehant, M. Fiammante, Mathieu Lederlin, Guillaume Chassagnon, Gilbert Ferretti, Mickaël Ohana, V. Racine, Yann Diascorn, François Laurent, Hugo Veyssière, Pierre-Yves Brillet, Xavier Durando, J. Behr, Antoine Khalil, E. Verdier, Imad Bousaid, Caroline Caramella, E. Sinitambirivoutin, T. Besson, P. Cuingnet, Alexandre Sadate, Lucie Cassagnes, Angeline Ginzac
Publikováno v:
Diagnostic and Interventional Imaging
Diagnostic and Interventional Imaging, 2020, 101 (12), pp.803-810. ⟨10.1016/j.diii.2020.10.004⟩
Diagnostic and Interventional Imaging, Elsevier, 2020, 101 (12), pp.803-810. ⟨10.1016/j.diii.2020.10.004⟩
Diagnostic and Interventional Imaging, 2020, 101 (12), pp.803-810. ⟨10.1016/j.diii.2020.10.004⟩
Diagnostic and Interventional Imaging, Elsevier, 2020, 101 (12), pp.803-810. ⟨10.1016/j.diii.2020.10.004⟩
International audience; Purpose: The purpose of this study was to create an algorithm to detect and classify pulmonary nodules in two categories based on their volume greater than 100 mm3 or not, using machine learning and deep learning techniques.Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1662c4a225e9c5a2d52de82a1d98e497
https://hal.science/hal-03054987/file/S2211568420302497.pdf
https://hal.science/hal-03054987/file/S2211568420302497.pdf
Autor:
Antoine Khalil, Clémentine Bouchez, Alice Guyard, Nathalie Théou-Anton, Morgan Tourne, Gérard Zalcman, Ghassen Soussi, J. Pluvy, Jamila Ammar, Valérie Gounant, S. Brosseau, Mégane Collin, Marina Nguenang
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Background Choroidal metastases are the most common eye metastatic site. The prevalence of choroidal metastases in NSCLC patients has been reported to vary from 0.2 to 7% in historical series. Although previously reported, little is known about choro
Autor:
Valérie Gounant, Baptiste Abbar, Claire Danel, Sandra Assoun, Nathalie Théou-Anton, Marina Nguenang, Johan Pluvy, Aurélie Cazes, Antoine Khalil, Céline Namour, Gérard Zalcman, Solenn Brosseau
Publikováno v:
Lung Cancer
Lung Cancer, Elsevier, 2019, 132, pp.65-71. ⟨10.1016/j.lungcan.2019.04.005⟩
Lung Cancer, Elsevier, 2019, 132, pp.65-71. ⟨10.1016/j.lungcan.2019.04.005⟩
Introduction Tumor mutational burden (TMB) correlates with response to immune checkpoint inhibitors (ICI) in advanced non-small-cell lung cancer (aNSCLC). We hypothesized that TP53 mutations could reflect TMB and be associated with ICI benefit. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87b57ffc47fff47d3b28b188ab317d4
https://hal.archives-ouvertes.fr/hal-03477631/file/S0169500219303927.pdf
https://hal.archives-ouvertes.fr/hal-03477631/file/S0169500219303927.pdf
Autor:
Johan Pluvy, Valérie Gounant, Marina Nguenang, Solenn Brosseau, Sandrine Stelianides, Bruno Crestani, Gérard Zalcman, Claire Danel, Antoine Khalil
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-5 (2019)
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-5 (2019)
Background Sporadic lymphangioleiomyomatosis (LAM) is a rare form of diffuse parenchymal lung disease. PD-1 blocking antibodies constitute an essential treatment option for advanced non-small-cell lung cancer (NSCLC). The effect of immune checkpoint
Autor:
Keyvan Razazi, Antoine Parrot, Antoine Khalil, Michel Djibre, Valerie Gounant, Jalal Assouad, Marie France Carette, Muriel Fartoukh, Jacques Cadranel
Publikováno v:
European Respiratory Journal. 45:756-764
Severe haemoptysis due to nonsmall cell lung cancer (NSCLC) is considered a grim condition, and there is still scarce data on its characteristics and outcome, despite new imaging and treatment modalities. This retrospective study sought to describe t
Autor:
Gérard Zalcman, Aurélie Cazes, Anne Bergeron, Nathalie Théou-Anton, Véronique Meignin, Valérie Gounant, Roland Smonig, Solenn Brosseau, C. Naltet, Mathilde Neuville, Antoine Khalil, Nidaa Mikail
Publikováno v:
Clinical lung cancer. 19(1)
Autor:
P. Créquit, Antoine Khalil, Bernard Milleron, Marie Wislez, Anne-Marie Ruppert, Valérie Gounant, Jacques Cadranel, Martine Antoine, Armelle Lavolé, Marie-France Carette, J. Assouad
Publikováno v:
Diagnostic and Interventional Imaging. 95(7-8):721-725
Lung cancer (LC) is a major public health issue because of its frequency, but especially because of the severity of this disease. The epidemiology has changed with an increased incidence in non-smokers and women. The ATS/ERS/IASLC classification of a
Publikováno v:
Diagnostic and interventional imaging. 97(10)
Lung cancer is the leading cause of cancer death worldwide. Prognosis and treatment outcomes are known to be related to the disease stage at the time of diagnosis. Therefore, an accurate assessment of the extent of disease is critical to determine th